The utilization of antithrombotic prophylaxis for atrial fibrillation in a geriatric rehabilitation hospital

Journal of the American Geriatrics Society

Volumn 44, Issue 6, 1996, Pages 708-711

  Lawson, Fiona ^a   McAlister, Finlay ^a,b   Ackman, Margaret ^a   Ikuta, Roland ^a   Montague, Terrence ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOT LYSIS; FEMALE; GERIATRICS; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROPHYLAXIS; REHABILITATION MEDICINE; STROKE; TREATMENT OUTCOME;

EID: 0029975229     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb01837.x     Document Type: Article

References (46)

1. Phillips SJ, Whisnant JP, O'Fallon WM et al. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 1990;65:344-359.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: A major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 1987;147:1561-1564.
3. Lake FR, McCall MG, Cullen KJ et al. Atrial fibrillation and mortality in an elderly population. Aust NZ J Med 1989;19:321-326.
4. Albers GW. Atrial fibrillation and stroke: Three new studies, three remaining questions. Arch Intern Med 1994;154:1443-1448.
5. Wolf PA, Abbott R, Kannel W. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
6. Levine HJ, Pauker SG, Salzman EW. Antithrombotic therapy in valvular heart disease. Chest 1989;95(suppl):98S-106.
7. Petersen P, Boysen G, Godtfredsen J et al. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989;i:175-179.
8. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990;323:1505-1511.
9. Connolly SJ, Laupacis A, Gent M et al. Canadian Atrial Fibrillation Anticoagulation Study. J Am Coll Cardiol 1991;18:349-355.
10. Stroke Prevention in Atrial Fibrillation Investigators. The Stroke Prevention in Atrial Fibrillation Study: Patient characteristics and final results. Circulation 1991;84:527-539.
11. Ezekowitz MD, Bridgers SL, James KE et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992;327:1406-1412.
12. European Atrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ishaemic attack or minor stroke. Lancet 1993;342:1255-1262.
13. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994;343:687-691.
14. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
15. Hendry A, Campbell AM, Campbell G et al. Antithrombotic therapy prescribed for patients with non-rheumatic atrial fibrillation. Scott Med J 1994;39:110-111.
16. Gottlieb LK, Salem-Schatz S. Anticoagulation in atrial fibrillation: Does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med 1994;154:1945-1953.
17. Chang HJ, Bell JR, Deroo DB et al. Dartmouth Primary Care COOP Project. Physician variation in anticoagulating patients with atrial fibrillation. Arch Intern Med 1990;150:83-86.
18. Bath PMW, Prasad A, Brown MM, MacGregor GA. Survey of use of anticoagulation in patients with atrial fibrillation. Br Med J 1993;307:1045.
19. Lip GYH, Tean KN, Dunn FG. Treatment of atrial fibrillation in a district general hospital. Br Heart J 1994;71:92-95.
20. Kutner M, Nixon G, Silverstone F. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med 1991;151:1950-1953.
21. McCrory DC, Matchar DB, Samsa G et al. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 1995;155:277-281.
22. Montague TJ, Ikuta RM, Wong RY et al. Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two-year period (1987-1989). Am J Cardiol 1991;68:843-847.
23. Rogers LQ, Johnson KC, Arheart KL. Current physician screening and treatment of hypercholesterolemic patients. Am J Med Sci 1993;306:124-128.
24. Tsuyuki RT, Teo KK, Ikuta RM et al. Mortality risk and patterns of practice in 2,070 patients with acute myocardial infarction, 1987-92. Relative importance of age, sex, and medical therapy. Chest 1994;105:1687-1692.
25. The Clinical Quality Improvement Network (CQIN) Investigators. Low incidence of assessment and modification of risk factors in acute care patients at high risk for cardiovascular events, particularly among females and the elderly. Am J Cardiol 1995;76:570-573.
26. Avorn J. Benefit and cost analysis in geriatric care: Turning age discrimination into health policy. N Engl J Med 1984;310:1294-1301.
27. Wetle T. Age as a risk factor for inadequate treatment. JAMA 1987;258:516.
28. Wong JB, Salem DN, Pauker SG. You're never too old. N Engl J Med 1993;328:971-975.
29. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994;120:897-902.
30. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989;87:144-152.
31. van der Meer FJM, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy: An analysis of risk factors. Arch Intern Med 1993;153:1557-1562.
32. Launbjerg J, Egeblad H, Heaf J et al. Bleeding complications to oral anticoagulant therapy: Multivariate analysis of 1010 treatment years in 551 outpatients. J Intern Med 1991;229:351-355.
33. Redwood M, Taylor C, Bain J, Matthews JH. The association of age with dosage requirement for warfarin. Age Ageing 1991;20:217-220.
34. Gurwitz JH, Avorn J, Ross-Degnan D et al. Aging and the anticoagulant response to warfarin therapy. Ann Intern Med 1992;116:901-904.
35. Fihn SD, McDonnell M, Martin D et al. Risk factors for complications of chronic anticoagulation: A multicenter study. Ann Intern Med 1993;118:511-520.
36. Petty GW, Lennihan L, Mohr JP et al. Complications of long-term anticoagulation. Ann Neurol 1988;23:570-574.
37. Petitti DB, Strom BL, Melmon KL. Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhage. Am J Med 1986;81:255-259.
38. Gurwitz JH, Goldberg RJ, Holden A et al. Age-related risks of long-term oral anticoagulant therapy. Arch Intern Med 1988;148:1733-1736.
39. Adams JN, Gautam PC. Warfarin therapy in the elderly. Br J Hosp Med 1994;51:392-393.
40. Wickramasinghe LSP, Basu SK, Banasl SK. Long-term oral anticoagulant therapy in elderly patients. Age Ageing 1988;17:388-396.
41. Forfar JC. A seven-year analysis of haemorrhage in patients on long- term anticoagulant treatment. Br Heart J 1979;42:128-132.
42. Adams JN, Gautam PC. Anticoagulant therapy in elderly patients. J Clin Exp Gerontol 1992;14:183-196.
43. Tabibian N. Acute gastrointestinal bleeding in anticoagulated patients: A prospective evaluation. Am J Gastroenterol 1989;84:10-12.
44. Sixty Plus Reinfarction Study Research Group. Risk of long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 1982;i:64-68.
45. Moulton AW, Singer DE, Haas JS. Risk factors for stroke in patients with non-rheumatic atrial fibrillation: A case-control study. Am J Med 1991;91:156-161.
46. Barnett HJM, Eliasziw M, Meldrum HE. Drugs and surgery in the prevention of ischemic stroke. N Engl J Med 1995;332:238-248.